{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:31Z","timestamp":1793814031491,"version":"4.6.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.carrev.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T16:55:20Z","timestamp":1719939320000},"page":"50-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Outcomes in transcatheter aortic valve replacement (TAVR) patients requiring red blood cell transfusion: A nationwide perspective"],"prefix":"10.1016","volume":"70","author":[{"given":"Mohsin Sheraz","family":"Mughal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan M.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Yarkoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Waqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najam","family":"Wasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2024.06.019_bb0005","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","article-title":"On behalf of the PARTNER 3 investigators. Transcatheter aortic-valve replacement in low-risk patients at five years","volume":"389","author":"Mack","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2024.06.019_bb0010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.athoracsur.2018.11.022","article-title":"Association between red blood cell transfusion and clinical outcomes among patients undergoing Transcatheter aortic valve replacement","volume":"107","author":"Apostolidou","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.carrev.2024.06.019_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcin.2019.08.015","article-title":"The effect and relationship of frailty indices on survival after Transcatheter aortic valve replacement","volume":"13","author":"Kiani","year":"2020","journal-title":"J Am Coll Cardiol Intv"},{"issue":"1","key":"10.1016\/j.carrev.2024.06.019_bb0020","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jtcvs.2019.03.043","article-title":"Trends and outcomes of red blood cell transfusion in patients undergoing transcatheter aortic valve replacement in the United States","volume":"159","author":"Kolte","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.carrev.2024.06.019_bb0025","first-page":"E44","article-title":"Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation","volume":"89","author":"Seiffert","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2024.06.019_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjcard.2014.11.033","article-title":"Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent Transcatheter aortic valve replacement","volume":"115","author":"DeLarochelli\u00e8re","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2024.06.019_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2018.09.041","article-title":"Blood disorders in patients undergoing Transcatheter aortic valve replacement","volume":"12","author":"De Larochelli\u00e8re","year":"2019","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2024.06.019_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2017.06.024","article-title":"Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation","volume":"244","author":"Rheude","year":"2017","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2024.06.019_bb0045","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3325\/cmj.2007.6.814","article-title":"Quality of life outcome of critical care survivors eighteen months after discharge from intensive care","volume":"48","author":"Fildissis","year":"2007","journal-title":"Croat Med J"},{"issue":"3","key":"10.1016\/j.carrev.2024.06.019_bb0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.MLR.0000053021.93198.96","article-title":"Length of stay data as a guide to hospital economic performance for ICU patients","volume":"41","author":"Rapoport","year":"2003","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.carrev.2024.06.019_bb0055","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jacc.2016.11.033","article-title":"2016 annual report of the Society of Thoracic Surgeons\/American College of Cardiology Transcatheter valve therapy registry","volume":"69","author":"Grover","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2024.06.019_bb0060","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.athoracsur.2018.11.070","article-title":"Predictors of cardiac surgery patients who tolerate blood conservation in cardiac surgery","volume":"107","author":"Mori","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2024.06.019_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.amjcard.2022.09.003","article-title":"Transcarotid versus Transfemoral Transcatheter aortic valve replacement (from a propensity-matched comparison)","volume":"185","author":"Hoover","year":"2022","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924005578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838924005578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:26:24Z","timestamp":1738887984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924005578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":13,"alternative-id":["S1553838924005578"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2024.06.019","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in transcatheter aortic valve replacement (TAVR) patients requiring red blood cell transfusion: A nationwide perspective","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}